Skip to content

Why curing HIV may be like curing cancer – and may be as difficult

Monsef Benkirane at the HIV Cure and Cancer Forum, IAS 2017. Photo by Marcus Rose/IAS

Can we achieve a complete HIV cure in more patients?

Michael Louella at the HIV Cure and Cancer Forum, IAS 2017. Photo by Marcus Rose/IAS

High frequency of recurrent high-grade pre-cancerous anal lesions in HIV-positive MSM

Direct-acting antivirals for hepatitis C not linked to higher liver cancer risk in most studies

Gregory Dore at the International Liver Congress 2017. Photo by Liz Highleyman, hivandhepatitis.com

Poppers linked to increased risk of some cancers in older MSM without HIV

Co-infection with HCV increases cancer risk for people with HIV

Are people with HIV and HCV co-infection who are cured of hepatitis C with DAAs at increased risk for liver cancer?

Nicolás Merchante at CROI 2017. Photo by Liz Highleyman, hivandhepatitis.com

Stopping smoking cuts the risk of some cancers quickly in people with HIV

Leah Shepherd at CROI 2017. Photo by Liz Highleyman, hivandhepatitis.com

Treatment or watchful waiting for cervical abnormalities in women with HIV?

Sharon Greene at CROI 2017. Photo by Liz Highleyman, hivandhepatitis.com